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Interferon-v regulation of human renal cortical epithelial cell-derived
monocyte chemotactic peptide-!. The chemoattractant signal(s) that
results in the transmigration of monocytes/macrophage into the tubu-
lointerstitium during acute inflammation is not known. Monocyte
chemotactic peptide-l (MCP- 1), a recently described chemotactic cy-
tokine, may function as both a potent monocyte chemotaxin and
activator in renal inflammation. We have studied the proinflammatory
conditions in which cultured human renal cortical epithelial cells
(RCEC) of tubular origin may be stimulated to produce MCP-l. RCEC
were stimulated in a dose-time dependent manner with: IL-l/3 (0.01 to
1.0 ng/ml), TNF (0.1 to 10 ng/ml), LPS (0.1 to 10 jg/ml) or INF-y
(10—1000 U/mi). Conditioned media from RCEC stimulated with either
IL-113 or INF-y produced a monocyte chemoattractant activity which
was significantly suppressed with neutralizing antibody to MCP-l.
Stimulation of RCEC with either IL-113 or INF-y resulted in a significant
(4- to 5-fold) increase in steady state levels of MCP-l mRNA. MCP-l
antigenic peptide in RCEC conditioned media was significantly in-
creased over control (2- to 2.5-fold) after stimulation with either IL-1/3
or INF-y. In contrast, production of interleukin-8 (IL-8), a neutrophil
chemotactic cytokine, was not stimulated by INF-yin RCEC. Thus, the
chemokine signaling repertoire of renal tubule cells may be selectively
controlled by INF-y.
Acute renal failure leading to permanent loss of renal function
is directly associated with tubulointerstitial inflammation in a
number of kidney diseases, including systemic lupus erythema-
tosis, systemic vasculitis, acute interstitial nephritis and renal
allograft rejection. Even in predominantly glomerulonephritic
diseases the component of tubulointerstitial inflammation most
closely predicts permanent loss of renal function [1, 2]. The
histologic hallmark of tubulointerstitial inflammation is the
migration of immune cells, including neutrophils, lymphocytes
and mononuclear phagocytes into the renal tubulointerstitium.
The types and number of inflammatory cells present within
the tubulointerstitial compartment is related to both the under-
lying disease process and the temporal stage of the inflamma-
tory response. In human renal inflammatory disease and animal
models of interstitial nephritis, lymphocytes and neutrophils are
typically seen early in the course of the acute inflammatory
response, at days 1 and 2. This is followed by the recruitment of
monocytes in addition to lymphocytes at days 5 to 7 [3—51. The
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temporal sequence of chemotactic signals that effect inflamma-
tory cell chemotaxis and the regulation of these signals in the
kidney are not known. Monocyte chemotactic peptide-1
(MCP-1) is a chemotactic cytokine of the "CC" supergene
family that has recently been described in humans and may
participate in the organized recruitment of monocytes/macro-
phage into tissues and organs, including the renal tubulointer-
stitial compartment [61.
In addition to inducing monocyte chemotaxis at n concen-
trations, MCP-1 also activates these cells, causing augmented
cytostatic activity against several tumor cell lines, stimulating
the respiratory burst, and inducing the release of lysosomal
enzymes [6]. MCP-1 is produced by a variety of immune and
non-immune cells, including blood mononuclear cells [7], en-
dothelial cells [8, 9], fibroblasts [10—13], smooth muscle cells
[14] and several tumor cell lines [6].
Depending on the cell type studied, interleukin 113 (IL-1f3),
lipopolysaccaride (LPS) and tumor necrosis factor-a (TNF)
have been shown to function as primary proinflammatory
stimuli for MCP- 1 mRNA expression and/or antigenic peptide
production [11]. However, interferon-y (INF-y), a potent prom-
flammatory agonist, has not been described as a stimulus for
MCP- I production in non-immune cells. INF- y is a secreted
peptide product of activated T lymphocytes that has both
immunoregulatory and proinflammatory actions [15—171. A sin-
gle type of cell membrane receptor for this multifunctional
polypeptide has been found in a number of cell types and is
believed to be present on most human cell types [18]. The
immunoregulatory and proinflammatory action of INF-y in-
cludes inducing the expression of MHC Class II [19] and Fc
receptors [20], regulating the production of IL-i, interleukin 2
(IL-2) and TNF, activating human monocyte cytotoxicity [21],
modulating class selection of immunoglobulins [22], and poten-
tiating natural killer cell activity [23]. INF-y may help potenti-
ate lymphocyte-tissue cell interactions in the kidney by increas-
ing ICAM-l expression on the surface of glomerular mesangial
cells [24] and on tubule epithelial cells [25]. In addition, INF-y
may increase MHC Class II and HLA expression on tubule
epithelial cells, thus facilitating recognition of renal allograft
tubulointerstitium by host immune effector cells [26, 27].
In this in vitro study we report the capacity of human renal
cortical epithelial cells (RCEC) to both express steady state
levels of MCP- 1 mRNA and secrete significant levels of biolog-
ically active MCP- 1 and MCP- 1 antigen after stimulation. IL- lf3
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and INF-y proved to be the most potent and consistent stimuli
of MCP-l production. However, INF-y was not found to
stimulate production of interleukin-8 (IL-8), a potent chemotac-
tic cytokine for neutrophils and possibly lymphocytes [28, 11].
This disparant response of chemotactic cytokine production by
INF-y stimulated RCEC may be a potential means of regulating
the types of inflammatory cells recruited into the tubulointer-
stitial compartment during inflammation.
Methods
Cell culture
Human renal cortex-derived epithelial cells were isolated
using a variation of a previously reported technique [29].
Briefly, 2 cm3 of normal human renal cortex was obtained from
the non-involved pole from patients undergoing elective ne-
phrectomy for hypernephroma or transitional cell carcinoma,
and placed in ice-cold sterile normal saline. The capsule was
removed, the medulla dissected away, and the cortex diced in
cold sterile saline to form a slurry of approximately 1 to 2 mm
pieces. The slurry was transferred into a sterile flask containing
150 to 200 ml 0.25% trypsin (porcine) in phosphate buffered
saline, and gently stirred for 30 minutes at 37°C. The contents of
the flask were then filtered through one layer of sterile gauze
and the filtrate was centrifuged at 30 x g for 10 minutes. The
supernatant was discarded and the pellet was resuspended in 20
to 30 ml of Dulbecco's Modified Eagle Medium (DMEM) with
10% fetal bovine serum (FBS), 1% glutamine, 1% streptomycin,
and 1% penicillin. The mixture was placed in a 75 cm2 polysty-
rene tissue culture flask (Corning) and maintained at 37°C with
95% air/5% CO2. After 24 hours of incubation, the media was
gently replaced to remove tissue debris and non-adherent cells.
After 7 to 10 days the confluent cells underwent first passage
using 0.25% trypsin in PBS. All experiments were conducted on
third and fourth passage cells.
Cell characterization
The cultured renal cortical cells at passage three or four were
characterized with monoclonal immunostaining and hormonal
stimulation by cAMP. Minimal or no staining was seen for
desmin or factor VIII-vWF. All cells showed moderate staining
for actin. Bright fluorescence, consistent with intermediate
filaments, was seen for all cells using the anti-cytokeratin
monoclonal antibody. This monoclonal antibody staining pat-
tern is consistent with a homogeneous primary culture of cells
of epithelial origin [30, 31].
Hormonal stimulation by cAMP was used to further delineate
the origin of these epithelial cells. Confluent RCEC cultures
from two subjects were incubated with l0— M parathyroid
hormone (PTH), 10 M calcitonin and 10—6 M arginine vaso-
pressin (AVP) for 15 minutes. Supernatants were then replaced
with a solution containing 150 m KC1, 5 m potassium
phosphate, 2 mi EDTA and 0.5 mM 3-isobutyl-1-methylxan-
thine (pH 6.8), and the cells were scraped into this medium; the
suspension was then immediately sonicated and boiled for five
minutes. Samples from both the plate supernatants and cell
fraction were stored frozen for measurement of cAMP after
acetylation by a standard radioimmunoassay performed by the
University of Michigan Diabetes Research and Training Center.
Stimulation with AVP failed to increase in cAMP. In the first
subject, stimulation of RCEC with PTH and calcitonin resulted
in a 3.7- and 1.4-fold increase in cell fraction and 3.7- and
2.2-fold increase in supernatant cAMP over controls, respec-
tively. In the second subject calcitonin stimulation increased
cell fraction and supernatant cAMP 1.3- and 3.4-fold over
controls, respectively. These results are compatible with hor-
mone sensitive, renal epithelial cells of tubule origin [29, 32].
Monocyte chemotaxis assay
Human peripheral blood mononuclear cells were harvested
as previously described [33] and resuspended in Hanks media at
a concentration of four million cells per ml for use in the
monocyte chemotaxis assay. RCEC were stimulated for 8 to 24
hours in serum-free media (DMEM) with IL-lp, TNF, LPS or
INF-y, and then the cell supernatants were harvested and
frozen. At the time of assay, supernatants were thawed, diluted
1:20 with Hanks media, and divided into two samples which
were incubated for 30 minutes at 37°C with either 1:1000 normal
rabbit sera or 1:1000 rabbit anti-human MCP-1 antibody [34].
These supernatants were then loaded in duplicate into the lower
wells and peripheral blood mononuclear cells into the upper
wells of a 12-well modified Boyden chemotaxis chamber with a
5 sm pore size polycarbonate membrane filter (Nucleopore
Corp) placed between the lower and upper wells. After the
chambers were incubated at 37°C with 95% air/5% CO2 for 90
minutes the filters were removed and the side of the filter facing
the upper wells were squeegeed clean. The filters were then air
dried for 10 to 20 minutes, fixed in 100% methanol for 10
minutes, air dried for 10 to 20 minutes, stained with toluidine
blue for 90 minutes, washed with distilled water, placed on glass
slides and, after air drying for 20 to 30 minutes, overlaid with
immersion oil and glass cover slips. Using an oil immersion 50x
objective (Olympus Corp), five random 500x fields were
counted for each of the duplicate wells, and the mean cells per
well of the combined total of ten cell counts was determined.
The assay was run with concomitant negative (Hanks, normal
rabbit sera, rabbit anti-human MCP-1 sera) and positive
(1O8fMLP) control samples.
Northern blot analysis
Total cellular RNA from the stimulated renal cortical cells
was isolated using a modification of the method of Chirgwin et
al [35] and Jonas, Sargent and Davis [36]. Total RNA was
separated by Northern blot analysis using formaldehyde in 1%
agarose gels, transblotted to nitrocellulose, baked, prehybrid-
ized, and then hybridized with a 32P 5' end-labeled thirty-mer
oligonucleotide probe complementary for human MCP- 1 (5'-
TFGGG1TTGCTTGTCCAGGTGGTCCATGGA-3) under con-
ditions previously defined [37]. Autoradiograms were quantified
using video densitometry with Scan Analysis (Specom Re-
search) on a Macintosh IIfx (Apple Computers). Equivalent
loading of total RNA per lane was assessed by ethidium
bromide stained 28S and 18S rRNA.
MCP-1 and IL-8 ELISA
MCP-1 and IL-8 antigen was quantitated using a modified,
double-ligand ELISA method, as previously described [34, 38,
39]. Briefly, flat-bottomed 96-well microtiter plates (Nunc Im-
muno-Plate I 96-F) were coated with rabbit anti-IL-8 or MCP- 1
antibody (9.5 mg in 100 ml, 0.1 M NaHCO3, pH 9.6) for 16 hours
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at 4°C and then washed with phosphate buffered saline, pH
7.5/0.5% Tween-20 (washing buffer). Nonspecific binding sites
were blocked with 2% bovine serum albumin in washing buffer
and incubated for one hour at 37°C. Plates were rinsed three
times with washing buffer and diluted samples (50 ml) in
duplicate were followed by incubation for 120 minutes at 37°C.
Plates were washed three times, biotinylated rabbit anti-MCP-l
or anti-IL-8 antibody (final concentration 1:2000) was added,
and plates were incubated for 90 minutes at 37°C. Plates were
washed three times, then streptavidin-peroxidase conjugate
(Dakopatts, Denmark) was added and incubated for 30 minutes
at 37°C. Plates were washed three times, and citrate phosphate-
buffered orthophenylenediamine solution (Dakopatts, Den-
mark) was added and incubated for approximately five minutes
at room temperature to the desired extinction. The reaction was
then terminated with 3 M H2S04. Plates were read at 490 nm in
an ELISA reader. Standards were 1/2 log dilutions of recombi-
nant human IL-8 or MCP-1, from 0.05 pg to 1000 ng per well.
This ELISA method consistently detected IL-8 and MCP-1 at
concentrations above 50 pglml.
Reagents
DMEM was from Whittaker (Walkersvile, Maryland, USA).
Trypsin, glutamine, penicillin, streptomycin was purchased
from Hazleton (Lenexa, Kansas, USA). Fetal bovine serum
(FBS) was from Biocell (Carson, California, USA). LPS (E. coli
0111:B4), PTH, and AVP was from Sigma Chemical Co. (St.
Louis, Missouri, USA). Human recombinant IL-1j3 with a
specific activity of 30 U/ng was a gift of the Upjohn Co
(Kalamazoo, Michigan, USA). Human recombinant TNF with
specific activity of 22 U/ng was supplied by Genetech (South
San Francisco, California, USA). Human recombinant INF-y
(100 pg), IL-8 (25 g) and MCP-l (20 jsg) was purchased from
Peprotech (Rocky Hill, New Jersey, USA). IL-8 and MCP-l
antiserum was produced by immunization of rabbits with re-
combinant human IL-8 or MCP- 1 in multiple intradermal sites
with complete Freund's adjuvant (Sigma [18]). IL-8 and MCP-l
antiserum, in concentrations used in the ELISA, reacted with
human recombinant IL-8 and MCP-1 in Western analysis,
respectively, and failed to cross-react with CTAP-III, NAP-2,
beta-thromboglobulin, GRO/MGSA or platelet factor 4. Mono-
clonal antibodies were: aDesmin (Labsystems, Helsinki, Fin-
land), aCytokeratin and aActin (Enzo Diagnostics, Inc., New
York, New York, USA), aVWF-Factor VIII (Miles, Inc.,
Kankakee, Illinois, USA), aVimentin (Boehringer Mannheim
Biochemicals, Indianapolis, Indiana, USA).
Statistical analysis
Calculation of descriptive statistics and analysis of variance
between groups were performed on a MacIntosh IIcx using
Statview II (Abacus Concepts) statistical analysis program.
That proinflammatory agonist that stimulated a maximal re-
sponse (either steady state mRNA or antigenic peptide produc-
tion) for each of the RCEC cultures used in a particular
experiment was defined as the maximal or 100% response; all
other proinflammatory or control responses for that particular
RCEC culture were then scaled as a ratio to this response, that
is, the "percent of maximal response." Means are expressed
SE.
Table I. Anti-MCP-1 antibody suppressable human monocyte
chemotactic activity expressed as mean number of monocytes SE
which have transmigrated a membrane filter towards conditioned
media derived from RCEC stimulated by IL-l/3, TNF-a, LPS or
INF-y for 8 hours
Normal seraa Anti-MCP-l ab % Reduction
Control 0.3 0.2 0 0.0 100
IL-1/32 ng/ml 59.6 3.7 14.4 2.6 76
TNF-a20 ng/m! 16.4 1.5 9.0 0.9 45
LPS 10 g/ml 51.4 3.6 32.5 1.6 37
INF-y 1000 U/rn! 6.0 1.1 0.2 0.1 97
RCEC conditioned media were diluted 1:20 with Hanks media.
a Normal rabbit sera and anti-MCP- 1 antibody at 1:1000 titer
Results
Monocyte chemotactic activity by stimulated RCEC
In initial experiments we determined if RCEC, in the pres-
ence of proinfiammatory agonists, could be stimulated to gen-
erate monocyte chemotactic activity. As shown in Table 1,
condition media from RCEC stimulated with either IL- 1/3,
TNF, LPS or INF-y and preincubated with normal rabbit sera
induced the chemotaxis of significantly (P < 0.01) more mono-
cytes than supernatants harvested from unstimulated control
RCEC. The strongest individual stimuli of monocyte chemotac-
tic activity were IL-1/3 and LPS, which resulted in nearly a
200-fold increase in monocyte chemotaxis above control. Stim-
ulation with INF-y induced a 20-fold increase in monocyte
chemotaxis which was almost completely abolished by anti-
human MCP-l (P < 0.001). Thus, the predominant monocyte
chemotactic response induced by conditioned media from
INF-y stimulated RCEC was almost entirely anti-MCP-1 anti-
body suppressable.
MCP-1 gene expression
The above experiments demonstrated that RCEC could pro-
duce a monocyte chemotactic activity which was suppressed by
anti-MCP-l antibody. Therefore, we next assessed the ability of
proinflammatory stimuli to induce steady state levels of mRNA
expression by RCEC. Figure 1 is a representative Northern blot
showing the kinetic expression of RCEC-derived levels of
MCP-l steady state mRNA after stimulation by IL-1/3 (2.0
ng/ml), TNF (20 ng/ml), LPS (10 tg/ml) or INF-y (1000 U/mi).
MCP- 1 steady state mRNA was first evident at approximately
two to four hours post-stimulation. The two most potent
stimulatory signals for MCP-1 expression were IL-l13 and
INF-y.
A summary of the Northern blot analysis of MCP- 1 steady
state mRNA levels in six RCEC cultures after six to eight hours
of proinfiammatory stimulation is shown in Figure 2A. RCEC
stimulated with either IL-1/3 or INF-y demonstrated a signifi-
cant, increase (4- to 5-fold) in MCP-l mRNA levels as com-
pared to non-challenged cells (P < 0.05). TNF and LPS also
resulted in a modest increase in steady state MCP-l mRNA. In
Figure 2B a summary the response of steady state MCP-1
mRNA to increasing concentrations of INF-y is shown (N = 3).
MCP-1 steady state mRNA levels begin to increase above
control at INF-y concentrations of 10 to 100 U/mi, with
maximal stimulation of MCP-l mRNA seen at 1000 U/ml INF-y
(P < 0.05).
000W? in1 0 C (0 (00 0.1 CD 00 CM fl CD 00 .- CM (0 (0
zzz0 0 ii.-ip TNF LPS INF-G
2ng/mI 2Ong/mI 100 jig/mI 1000 iJmI
HOURS
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Fig. 1. Representative Northern blot of the kinetic response of MCP-1 steady state mRNA after stimulation by IL-1/3 (0.1 ng/ml), TNF (1.0 ng/ml),
LPS (1 g/ml) and INF-7 (1000 U/mI) from 0.5 to 6 hours. Equal total RNA loading per lane is demonstrated by ethidium bromide staining of 18S
and 28S rRNA on the blot.
Production of IL-8 and MCP-1 antigenic peptide
Having shown that MCP-l mRNA was expressed in both a
time and dose dependent fashion after stimulation by INF-y, we
next assessed the secretion of MCP-l antigenic peptide follow-
ing RCEC stimulation. As shown in Figure 3, significant levels
of RCEC-derived MCP-1 were detected after 8 to 12 hours of
stimulation by both IL-l/3 (P < 0.01) and INF-y (P < 0.05).
Stimulation by TNF or LPS also resulted in a modest increase
in MCP-l secretion over control. Modest, constitutive produc-
tion of MCP-l antigenic peptide was detected in cell superna-
tants from nonstimulated controls.
In previous studies, we showed that mRNA expression and
antigen production of IL-8, a neutrophil chemoattractant factor
of the "CXC" supergene family, was also stimulated by IL-i,
TNF and LPS [40]. However, we were unable to demonstrate
any consistent pattern of increased steady state levels of IL-8
mRNA expression after stimulation by INF-y (1 to 1000 U/mI
over 0.5 to 24 hours, data not shown). This disparity in INF-y
stimulated chemotactic cytokine production is also manifested
at the level of antigen production as shown in Figure 4. No
consistent stimulation of IL-8 secretion occurred at the concen-
tration of INF-y from 1 to 1000 U/ml. However, stimulation of
RCEC with INF-yresulted in up to a twofold increase in MCP-l
secretion over that seen with time matched controls.
Discussion
In this study we show that stimulated human renal cortical
epithelial cells in vitro can produce a biologically active, mono-
cyte chemotactic factor after stimulation with proinflammatory
agonists, including INF-y. This stimulated tubule cell-derived
monocyte chemotactic activity could be significantly blocked
by rabbit anti-human MCP-1 antibody. RCEC cultures were
shown to express significant levels of MCP-l mRNA and
secrete MCP-1 antigenic peptide after stimulation by either
IL-lf3 or INF-y. Finally, our results demonstrate that while
RCEC stimulation by INF-y resulted in increased MCP-1
production, this proinflammatory mediator did not result in
significant stimulation of either IL-8 mRNA or IL-8 antigen.
The capacity of renal tubule cells to secrete MCP- 1 in a
paracrine fashion after specific stimulation gives these cells the
capacity to generate a potent chemotactic gradient for mono-
cyte migration into the tubulointerstitial compartment. By
selectively secreting either a monocyte (MCP-1) or a neutrophil
(IL-8) chemotactic factor, it may be possible for renal tubule
epithelial cells to regulate the recruitment of different types of
peripheral blood inflammatory cells. Thus, after stimulation by
specific proinflammatory signals, renal tubule cells may func-
tion as effector cells of tubulointerstitial inflammation by pro-
ducing chemotactic factors for specific inflammatory cell migra-
tion.
Acute inflammation of the renal tubulointerstitium is signifi-
cant for the influx of large numbers of several types of inflam-
matory cells. In animal models of interstitial nephritis, a model
of delayed-type hypersensitivity, the predominant type of in-
flammatory cell migrating into the tubulointerstitium in the
early phase of the immune response (24 to 48 hr) is the
lymphocyte. Later, at approximately 48 to 72 hours, the recruit-
ment of monocytes/macrophage becomes apparent [3—5]. In a
fully engaged cell mediated inflammatory response of the tub-
ulointerstitium, monocytes/macrophage may contribute up to
40% of the cellular infiltrate [4]. Given our findings on the
chemotactic cytokine signaling potential of renal tubular cells
we propose one possible scenario that could account for inflam-
matory cell recruitment into the tubulointerstitial compartment:
(1) initial activation of resident interstitial macrophage (type II
interstitial cells) by anti-tubular cell or anti-tubular basement
membrane antibody resulting in secretion of IL-1/3 and TNF by
these cells; (2) IL-1/3 and TNF stimulates IL-8 secretion by
tubule cells that are in proximity to resident macrophage cells;
(3) an IL-8 chemotactic gradient is established between tubules
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Fig. 3. MCP-1 antigenic peptide production measured by ELISA ex-
pressed as percent of maximal response before (control) and after
stimulation by either IL-I 13, TNF, LPS or INF-y for 8 to 12 hours (N =
5, * P < 0.05, ** P < 0.01).
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Fig. 2. MCP-1 steady state mRNA levels expressed as the percent of
maximal response after stimulation by either: (A) IL -1 13, TNF, LPS, or
INF-y for 6 to 8 hours (N = 6, * P < 0.05) or (B) Increasing
concentration of INF--y (1 to 1000 U/mI) for 6 to 8 hours (N = 3, * J <
0.05 for 1000 vs. Control, 1, 10, or 100).
and peritubular capillaries, which results in the directed recruit-
ment of neutrophils and possibly lymphocytes from these
vessels; (4) lymphocytes produce INF-y after activation by
MHC restricted presentation of tubular antigens by antigen
presenting cells (type II interstitial cells/tubular cells/dendritic
interstitial cells) or by foreign Class II antigen (in the case of
renal allografts); (5) INF-y stimulates production of MCP-1 in
renal tubule cells in proximity to activated T-lymphocytes; (6) a
chemotactic MCP- 1 gradient for monocytes/macrophage is es-
tablished between tubule cells and the peritubular capillaries
resulting in the recruitment of monocytes/macrophage into the
tubulointerstitial compartment; (7) the recruited monocytes/
macrophage serve to amplify the inflammatory response by
increasing the presentation of local tissue antigen to T-lympho-
cytes, resulting in the further activation and proliferation of
cytotoxic T cells.
Both macrophage [411 and endothelial cells [8, 9] have been
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Fig. 4. Dose response of IL-8 and MCP-l antigenic peptide production
at 8 hours measured by ELISA and expressed as the average fold
increase over control after stimulation by INF--y (N = 2).
shown to produce MCP-1 and IL-8. Therefore, these cells may
also participate in generating monocyte and neutrophil chemo-
tatic gradients during acute tubulointerstitial inflammation.
However, a far greater cellular mass of tubule epithelial cells is
present in the kidney and poised to rapidly effect both mono-
cyte and neutrophil/lymphocyte chemotaxis and activation
through the stimulated production of MCP-1 and IL-8, respec-
tively. Thus, native or allograft kidney tubule cells may be
important effectors of inflammatory cell chemoattraction, espe-
cially in the first several days of the acute inflammatory
response. Future research into the in vivo production and
regulation of chemokines in renal inflammatory disease will
better define their pathobiologic role and significance.
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